RYBOX Mutual Fund (Rydex Biotechnology Fund Class A) is managed by Rydex Funds with $16.5M in net assets. RYBOX expense ratio is 1.64%, holding 75 positions across sectors including Health Care, Unknown, Other. Inception date: 2004-09-01.

RYBOX performance shows a YTD return of 18.77%. The 1-year return is 79.03% and the 5-year return is 11.38%. RYBOX dividend yield stands at 12.78%, paid annually.

RYBOX top holdings include Abbvie Inc (7.4%), Amgen Inc. (5.2%), Gilead Sciences Inc (5.0%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). View all RYBOX holdings, sector breakdown, or dividend history.

RYBOX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYBOX alternatives are available via the screener, along with tax-loss harvesting opportunities.